A new framework that rethinks the corrective and preventive action (CAPA) process by using a risk-based approach has been given the thumbs-up by the US Food and Drug Administration (FDA), with one ...
When FDA oversight detects violations of current good manufacturing practices (CGMPs) at a drug manufacturing facility, the owner is expected to respond with a corrective and preventive actions (CAPA) ...
The US Food and Drug Administration (FDA) has warned five medtech companies for failing to meet current good manufacturing practices (CGMP) requirements under the Quality System (QS) regulations. The ...
Establishing a corrective and preventive action (CAPA) system is a quality system regulation (QSR) requirement for medical device firms marketing products in the United States. Although FDA has always ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results